Brief: Onxeo Enters Clinical Research Agreement With Institut Curie

Valerio Therapeutics SA

04/02/2021 17:26

Feb 4 (Reuters) - ONXEO SA  ALONX.PA 
    * ONXEO ENTERS CLINICAL RESEARCH AGREEMENT WITH INSTITUT
CURIE TO
CONDUCT A PHASE 1B/2 CLINICAL TRIAL OF ASIDNA™ IN COMBINATION
WITH RADIOTHERAPY FOR TREATMENT OF HIGH-GRADE GLIOMA RELAPSE IN
CHILDREN
    * STUDY IS SUPPORTED BY A GRANT FROM EUROPEAN FIGHT KIDS
CANCER
PROGRAM

Source text for Eikon:  ID:nBw9gRHkqa 
Further company coverage:  ALONX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))